Skip to content

Manual Implantation of Full-Thickness Skin Microcolumns

Manual Implantation of Full-Thickness Skin Microcolumns for 'Donor-Free' Skin Renewal

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05223998
Enrollment
10
Registered
2022-02-04
Start date
2024-10-28
Completion date
2026-12-01
Last updated
2026-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burns, Wound of Skin

Brief summary

The objective of this study is to validate the proof of concept regarding the approach of manual implantation of full-thickness skin microcolumns (FTSMs) as coverage for open wounds without creating an additional donor scar and while also capitalizing on the wound healing benefits offered by full-thickness skin grafts.

Detailed description

Previously three patients have been successfully treated with the use of manual FTSM for wound coverage. To provide additional proof of concept data, this study will validate manual FTSM implantation on a larger scale with a 10-patient population. This will be measured by the following hypothesized parameters: time to re-epithelization, pigmentation, wound contraction, scar thickness, pain at the donor site and injury site healing outcome. The approach to testing this hypothesis will be to perform manual FTSM harvest, placement on the injured site, covered by an inert dressing for 10 patients with open wounds necessitating tissue coverage. The rationale is that although preliminary proof of concept data has already been obtained from three patients treated with FTSM implantation, additional proof of concept data would strengthen the conclusions made based on these cases.

Interventions

PROCEDUREFull-thickness skin microcolumns implantation

Surgical harvest and implantation of FTSM on an open wound requiring coverage.

Sponsors

The Metis Foundation
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Proof of concept

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* 8-85 years of age * 10-125 cm2 open wound on the scalp, neck, torso or extremities necessitating tissue coverage * Sufficiently healthy skin to serve as a donor site

Exclusion criteria

* Wound area involving the face\* * Wound area involving joints\* * Pregnancy * Prisoner * Active wound infection at potential treatment sites * Exposed muscle, joint, tendon, or bone within the wound bed

Design outcomes

Primary

MeasureTime frameDescription
Donor site re-epithelization between day 10 to 1410-14 daysDonor site re-epithelization between day 10 to 14

Secondary

MeasureTime frameDescription
Donor siteup to 6 monthsAssess donor site pigmentation, contraction, scar thickness and pain
Injured siteup to 6 monthsAssess injured site re-epithelization, pigmentation, contraction, scar thickness and pain

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORRodney Chan, MD

Metis Foundation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 14, 2026